Quick Takeaways
- Daniel Bradbury has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $499,766.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Daniel Bradbury and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CSTL | CASTLE BIOSCIENCES INC | Director | $441,696 | 21 May 2025 | ||
| VANI | Vivani Medical, Inc. | Director | $58,070 | 01 Jan 2026 | ||
| EQ | Equillium, Inc. | EXECUTIVE CHAIRMAN, Director, 10%+ Owner | 14 Feb 2025 | |||
| ICPT | INTERCEPT PHARMACEUTICALS, INC. | Director | 08 Nov 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|